MIAMI--(BUSINESS WIRE)--May 2, 2005--IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it received final approval on April 29, 2005 from the U.S. Food and Drug Administration (FDA ...
April 11, 2011 (UDDATED April 28, 2011) — The US Food and Drug Administration (FDA) has approved gabapentin enacarbil extended-release tablets (Horizant; GlaxoSmithKline and XenoPort Inc) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results